{"id":48726,"date":"2022-09-23T01:01:47","date_gmt":"2022-09-22T23:01:47","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-eyesouth-partners-celebrates-largest-incoming-doctor-class-since-its-founding-in-2017\/"},"modified":"2022-09-23T01:01:47","modified_gmt":"2022-09-22T23:01:47","slug":"correcting-and-replacing-eyesouth-partners-celebrates-largest-incoming-doctor-class-since-its-founding-in-2017","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-eyesouth-partners-celebrates-largest-incoming-doctor-class-since-its-founding-in-2017\/","title":{"rendered":"CORRECTING and REPLACING EyeSouth Partners Celebrates Largest Incoming Doctor Class Since Its Founding in 2017"},"content":{"rendered":"
\n

\n20 new doctors slated to join EyeSouth\u2019s affiliate practices throughout the country<\/i>\n<\/p>\n

ATLANTA–(BUSINESS WIRE)–Please replace the release with the following corrected version due to multiple revisions.\n<\/p>\n

<\/a><\/p>\n

\nThe updated release reads:\n<\/p>\n

\nEYESOUTH PARTNERS CELEBRATES LARGEST INCOMING DOCTOR CLASS SINCE ITS FOUNDING IN 2017<\/b>\n<\/p>\n

\n20 new doctors slated to join EyeSouth\u2019s affiliate practices throughout the country<\/i>\n<\/p>\n

\nEyeSouth Partners<\/a> (\u201cEyeSouth\u201d or the \u201cCompany\u201d) is proud to celebrate the addition of 20 incoming doctors to their affiliate practices during the fourth quarter of 2022, the largest doctor class introduced since its formation in 2017. All of the doctors are additive to pre-existing EyeSouth Partners affiliates who have been in network since EyeSouth\u2019s inception, found through the company\u2019s strategic recruiting efforts. EyeSouth Partners has steadily become the largest comprehensive ophthalmology platform in North America, with nearly one million patient visits in a year and an industry leading doctor retention rate.\n<\/p>\n

\n\u201cWith the ever-increasing number of Americans requiring critical eyecare, our society and EyeSouth needs to continue to grow by adding more highly qualified doctors to treat America\u2019s rising number of eyecare patients,\u201d said Rex Adams, Chief Executive Officer at EyeSouth Partners. \u201cEyeSouth has more than 270 affiliated doctors in more than 155 locations throughout the country, and I look forward to our continued growth and ability to hire even more qualified doctors in the years to come.\u201d\n<\/p>\n

\nEyeSouth and their affiliated practices welcome four glaucoma & cataract fellows, three retina fellows, two oculoplastic fellows, one pediatric fellow, four comprehensive ophthalmologists and six optometrists.\n<\/p>\n

\n\u201cOur success as a company is in large part due to our physician-led culture,\u201d said Scott Bullock, the President of EyeSouth Partners. \u201cAs one of EyeSouth\u2019s first executive leaders, our company was founded with a focus on our doctors, and I have personally welcomed nearly every doctor that we have hired since 2017. I am uniquely excited about our Class of 2022 given their numbers, their breadth of specialties, and their ability and willingness to help serve our patients and communities. This is one of the main reasons we have best in class results amongst our competitors and expect continued growth as we attract top talent.\u201d\n<\/p>\n

\n\u201cDoctors are welcomed into EyeSouth Partners as they would be welcomed into a new family,\u201d said Dr. Eugene Gabianelli, Co-founder of EyeSouth Partners and Georgia Eye Partners. \u201cWe created EyeSouth Partners in hopes of building an ecosystem which would allow doctors at all career stages to have the resources needed to thrive. It\u2019s satisfying to see how far the company has come already and to see so many new, talented doctors joining the teams of our various affiliates.\u201d\n<\/p>\n

\nEyeSouth Partners is physician-led organization and has 28 of its affiliate doctors participating in leadership or advisory roles, including a physician board, optometry board and junior physician board, representing doctors across every geography. The 98 percent retention rate of its ophthalmologists and a 97 percent retention rate amongst optometrists speaks volumes about the company\u2019s unique culture. Additionally, 80 percent of doctor hires have been from internal referrals.\n<\/p>\n

\n“As a physician with a deep background in research and education, I value MidWest Eye Center’s affiliation with EyeSouth Partners,” said Dr. Kristen Mendoza, a new glaucoma and cataract specialist at EyeSouth Partners\u2019 affiliate, MidWest Eye Center in Cincinnati, OH. “EyeSouth continually prioritizes and promotes new research and advancements in the industry so that all of the doctors in network can offer our patients the latest and greatest in technology to deliver the best care. They make it easier to stay in the know and collaborate with other glaucoma specialists in the network.”\n<\/p>\n

\nEyeSouth is an eye care-focused management services organization backed by Shore Capital Partners,<\/a> committed to partnering with leading doctors to build a premier network of eye care services in the U.S. EyeSouth\u2019s affiliate network consists of 32 practices with over 270 doctors providing medical and surgical eye care services at over 155 locations with surgery centers throughout Georgia, Texas, Louisiana, Florida, Tennessee, Ohio, Kentucky, Pennsylvania, Illinois and North Carolina.\n<\/p>\n

\nDoctors interested in applying to positions at EyeSouth Partners affiliate practices can email Scott Bullock at: scott.bullock@eyesouthpartners.com<\/a>.\n<\/p>\n

\nTo view all current job openings, visit: eyesouthpartners.com\/career-opportunities.<\/a>\n<\/p>\n

\nAbout EyeSouth Partners<\/b>\n<\/p>\n

\nHeadquartered in Atlanta, GA, EyeSouth Partners (\u201cEyeSouth\u201d) is an eye care management services organization committed to partnering with leading doctors to build a premier network of eye care services throughout the U.S. EyeSouth\u2019s partner practices\u2019 clinical mission is to provide high quality medical and surgical specialty eye care. EyeSouth supports its affiliated practices and physician partners with strategic guidance, administrative resources, operating expertise, and capital with an absolute focus on clinical quality and a patient-first culture. EyeSouth\u2019s affiliate network consists of more than 270 doctors providing medical and surgical eye care services with more than 155 locations throughout Georgia, Texas, Louisiana, Florida, Tennessee, Ohio, Kentucky, Pennsylvania, Alabama, Illinois and North Carolina. EyeSouth is backed by Shore Capital Partners, a Chicago-based private equity firm. For more information about EyeSouth Partners, please visit: www.eyesouthpartners.com<\/a>.\n<\/p>\n

\nAbout Shore Capital Partners<\/b>\n<\/p>\n

\nShore Capital, a Chicago-based private equity firm with offices in Nashville, is focused on microcap investments within the Healthcare, Food and Beverage, Business Services, and Real Estate industries. Shore supports management partners with capital, business development expertise, and industry knowledge to accelerate growth, fund acquisitions, and generate value for shareholders. Shore targets investments in proven, successful private companies with superior management teams, stable cash flow, and significant growth potential, including organic growth and growth through industry consolidation. Shore has approximately $3.0 billion of cumulative capital commitments through various investment vehicles. For more information, please visit: www.shorecp.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nJules Lydon
\n
(404) 383-0868
\n
julianna.lydon@eyesouthpartners.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

20 new doctors slated to join EyeSouth\u2019s affiliate practices throughout the country ATLANTA–(BUSINESS WIRE)–Please replace the release with the following corrected version due to multiple revisions. The updated release reads: EYESOUTH PARTNERS CELEBRATES LARGEST INCOMING DOCTOR CLASS SINCE ITS FOUNDING IN 2017 20 new doctors slated to join EyeSouth\u2019s affiliate practices throughout the country EyeSouth … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48726","6":"format-standard","7":"category-industry"},"yoast_head":"\nCORRECTING and REPLACING EyeSouth Partners Celebrates Largest Incoming Doctor Class Since Its Founding in 2017 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-eyesouth-partners-celebrates-largest-incoming-doctor-class-since-its-founding-in-2017\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CORRECTING and REPLACING EyeSouth Partners Celebrates Largest Incoming Doctor Class Since Its Founding in 2017 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"20 new doctors slated to join EyeSouth\u2019s affiliate practices throughout the country ATLANTA–(BUSINESS WIRE)–Please replace the release with the following corrected version due to multiple revisions. The updated release reads: EYESOUTH PARTNERS CELEBRATES LARGEST INCOMING DOCTOR CLASS SINCE ITS FOUNDING IN 2017 20 new doctors slated to join EyeSouth\u2019s affiliate practices throughout the country EyeSouth ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-eyesouth-partners-celebrates-largest-incoming-doctor-class-since-its-founding-in-2017\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-22T23:01:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220922005660\/en\/1580394\/21\/ESP_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-eyesouth-partners-celebrates-largest-incoming-doctor-class-since-its-founding-in-2017\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-eyesouth-partners-celebrates-largest-incoming-doctor-class-since-its-founding-in-2017\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"CORRECTING and REPLACING EyeSouth Partners Celebrates Largest Incoming Doctor Class Since Its Founding in 2017\",\"datePublished\":\"2022-09-22T23:01:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-eyesouth-partners-celebrates-largest-incoming-doctor-class-since-its-founding-in-2017\\\/\"},\"wordCount\":948,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-eyesouth-partners-celebrates-largest-incoming-doctor-class-since-its-founding-in-2017\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220922005660\\\/en\\\/1580394\\\/21\\\/ESP_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-eyesouth-partners-celebrates-largest-incoming-doctor-class-since-its-founding-in-2017\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-eyesouth-partners-celebrates-largest-incoming-doctor-class-since-its-founding-in-2017\\\/\",\"name\":\"CORRECTING and REPLACING EyeSouth Partners Celebrates Largest Incoming Doctor Class Since Its Founding in 2017 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-eyesouth-partners-celebrates-largest-incoming-doctor-class-since-its-founding-in-2017\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-eyesouth-partners-celebrates-largest-incoming-doctor-class-since-its-founding-in-2017\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220922005660\\\/en\\\/1580394\\\/21\\\/ESP_Logo.jpg\",\"datePublished\":\"2022-09-22T23:01:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-eyesouth-partners-celebrates-largest-incoming-doctor-class-since-its-founding-in-2017\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-eyesouth-partners-celebrates-largest-incoming-doctor-class-since-its-founding-in-2017\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-eyesouth-partners-celebrates-largest-incoming-doctor-class-since-its-founding-in-2017\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220922005660\\\/en\\\/1580394\\\/21\\\/ESP_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220922005660\\\/en\\\/1580394\\\/21\\\/ESP_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-eyesouth-partners-celebrates-largest-incoming-doctor-class-since-its-founding-in-2017\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CORRECTING and REPLACING EyeSouth Partners Celebrates Largest Incoming Doctor Class Since Its Founding in 2017\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CORRECTING and REPLACING EyeSouth Partners Celebrates Largest Incoming Doctor Class Since Its Founding in 2017 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-eyesouth-partners-celebrates-largest-incoming-doctor-class-since-its-founding-in-2017\/","og_locale":"en_US","og_type":"article","og_title":"CORRECTING and REPLACING EyeSouth Partners Celebrates Largest Incoming Doctor Class Since Its Founding in 2017 - Pharma Trend","og_description":"20 new doctors slated to join EyeSouth\u2019s affiliate practices throughout the country ATLANTA–(BUSINESS WIRE)–Please replace the release with the following corrected version due to multiple revisions. The updated release reads: EYESOUTH PARTNERS CELEBRATES LARGEST INCOMING DOCTOR CLASS SINCE ITS FOUNDING IN 2017 20 new doctors slated to join EyeSouth\u2019s affiliate practices throughout the country EyeSouth ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-eyesouth-partners-celebrates-largest-incoming-doctor-class-since-its-founding-in-2017\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-22T23:01:47+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220922005660\/en\/1580394\/21\/ESP_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-eyesouth-partners-celebrates-largest-incoming-doctor-class-since-its-founding-in-2017\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-eyesouth-partners-celebrates-largest-incoming-doctor-class-since-its-founding-in-2017\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"CORRECTING and REPLACING EyeSouth Partners Celebrates Largest Incoming Doctor Class Since Its Founding in 2017","datePublished":"2022-09-22T23:01:47+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-eyesouth-partners-celebrates-largest-incoming-doctor-class-since-its-founding-in-2017\/"},"wordCount":948,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-eyesouth-partners-celebrates-largest-incoming-doctor-class-since-its-founding-in-2017\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220922005660\/en\/1580394\/21\/ESP_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-eyesouth-partners-celebrates-largest-incoming-doctor-class-since-its-founding-in-2017\/","url":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-eyesouth-partners-celebrates-largest-incoming-doctor-class-since-its-founding-in-2017\/","name":"CORRECTING and REPLACING EyeSouth Partners Celebrates Largest Incoming Doctor Class Since Its Founding in 2017 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-eyesouth-partners-celebrates-largest-incoming-doctor-class-since-its-founding-in-2017\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-eyesouth-partners-celebrates-largest-incoming-doctor-class-since-its-founding-in-2017\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220922005660\/en\/1580394\/21\/ESP_Logo.jpg","datePublished":"2022-09-22T23:01:47+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-eyesouth-partners-celebrates-largest-incoming-doctor-class-since-its-founding-in-2017\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/correcting-and-replacing-eyesouth-partners-celebrates-largest-incoming-doctor-class-since-its-founding-in-2017\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-eyesouth-partners-celebrates-largest-incoming-doctor-class-since-its-founding-in-2017\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220922005660\/en\/1580394\/21\/ESP_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220922005660\/en\/1580394\/21\/ESP_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-eyesouth-partners-celebrates-largest-incoming-doctor-class-since-its-founding-in-2017\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"CORRECTING and REPLACING EyeSouth Partners Celebrates Largest Incoming Doctor Class Since Its Founding in 2017"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48726","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48726"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48726\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48726"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48726"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48726"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}